Sarcoidosis

4 trials 2 recruiting MedDRA PT
4 Registered trials
2 Recruiting
2 Unique sponsors
4 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
H Endocrinology (ATC H) 2
P Parasitology (ATC P) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Corticosteroid 2 substances
Phase III: 1 Phase II: 1 Phase I/II: 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

1 trial
  • Hospices Civils De Lyon Academic
    HYDROXYCHLOROQUINE SULFATE
    2022-502155-65-00 1 country 2024 n=140
    Recruiting

Phase II

1 trial

Phase I/II

2 trials
  • Xentria Inc. Commercial
    PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE; XTMAB-16
    2022-502877-41-00 6 countries n=47
    Not authorised
  • Xentria Inc. Commercial
    PREDNISOLONE SODIUM PHOSPHATE; XTMAB-16
    2022-502877-41-01 5 countries 2025 n=24
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Xentria Inc. Commercial 3 Phase II, Phase I/II 1
Hospices Civils De Lyon Academic 1 Phase III 1
New trials by year
2024
1
2025
1
← All indication landscapes